The bestselling resource on industrial chemical assessment just got better. A practical guide to biological monitoring for industrial chemical exposure assessment, the THIRD EDITION of INDUSTRIAL CHEMICAL EXPOSURE: GUIDELINES FOR BIOLOGICAL MONITORING has been completely revised to include the latest developments in the field. In addition to an update of each chapter, major revisions have been made to take into consideration new information available since the publication of the second edition. SEE WHAT'S NEW IN THE THIRD EDITION: Major changes to the sections on lead, benzene, trichloroethylene, and dimethylformamide Fourteen completely new topics: bromine, molybdenum, perchlorate, platinum, n-heptane, ethene, 1,3-butadiene trimethylbenzene, naphthalene, terpenes, acrylamide, pesticides, tetrahydrofuran, methyl tertiarybutyl ether, n-nitrosodiethylamine Discussion of the metabolic fate of chemicals Increased information on the threshold of adverse effects levels Development of biological monitoring methods for assessing the internal dose of additional chemicals This authoritative book summarizes what is known about biological monitoring for inorganic, organic and organometallic substances. It provides a summary table with practical recommendations, giving you quick and easy access to the data. With INDUSTRIAL CHEMICAL EXPOSURE: GUIDELINES FOR BIOLOGICAL MONITORING you will understand the objectives of biological monitoring, the types of biological monitoring methods, their advantages and limitations, as well as practical aspects that must be considered before initiating a biological monitoring program.

Biomonitoring—a method for measuring amounts of toxic chemicals in human tissues—is a valuable tool for studying potentially harmful environmental chemicals. Biomonitoring data have been used to confirm exposures to chemicals and validate public health policies. For example, population biomonitoring data showing high blood lead concentrations resulted in the U.S. Environmental Protection Agency's (EPA's) regulatory reduction of lead in gasoline; biomonitoring data confirmed a resultant drop in blood lead concentrations. Despite recent advances, the science needed to understand the implications of the biomonitoring data for human health is still in its nascent stages. Use of the data also raises communication and ethical challenges. In response to a congressional request, EPA asked the National Research Council to address those challenges in an independent study. Human Biomonitoring for Environmental Chemicals provides a framework for improving the use of biomonitoring data including developing and using biomarkers (measures of exposure), research to improve the interpretation of data, ways to communicate findings to the public, and a review of ethical issues.

In keeping with a congressional mandate (Public Law 104-484) and the Chemical Weapons Convention, the United States is currently destroying its chemical weapons stockpile. The Army must ensure that the chemical demilitarization workforce is protected from the risks of exposure to hazardous chemicals during disposal operations and during and after facility closure. Good industrial practices developed in the chemical and nuclear energy industries and other operations that involve the processing of hazardous materials include workplace monitoring of hazardous species and a systematic occupational health program for monitoring workers' activities and health. In this report, the National Research Council Committee on Review and Evaluation of the Army Chemical Stockpile Disposal Program examines the methods and systems used at JACADS and TOCDF, the two operational facilities, to monitor the concentrations of airborne and condensed-phase chemical agents, agent breakdown products, and other substances of concern. The committee also reviews the occupational health programs at these sites, including their industrial hygiene and occupational medicine components. Finally, it evaluates the nature, quality, and utility of records of workplace chemical monitoring and occupational health programs.

The National Human Monitoring Program (NHMP) identifies concentrations of specific chemicals in human tissues, including toxicologic testing and risk assessment determinations. This volume evaluates the current activities of the NHMP; identifies important scientific, technical, and programmatic issues; and makes recommendations regarding the design of the program and use of its products.

Since Operation Desert Shield/Desert Storm, Gulf War veterans have expressed concerns about health effects that could be associated with their deployment and service during the war. Although similar concerns were raised after other military operations, the Gulf War deployment focused national attention on the potential, but uncertain, relationship between the presence of chemical and biological (CB) agents and other harmful agents in theater and health symptoms reported by military personnel. Strategies to Protect the Health of Deployed U.S. Forces which is one of the four two-year studies, examines the detection and tracking of exposures of deployed personnel to multiple harmful agents.